Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization

Cancer Research

Volumn 62, Issue 1, 2002, Pages 262-270

  Shridhar, Viji ^a   Chien, Jeremy ^a   Staub, Julie ^a   Avula, Rajeswari ^a   Smith, David I ^a   Sen, Ami ^b   Kovats, Steve ^b   Lillie, Jim ^b   Lee, John ^c  

^a MAYO CLINIC   (United States)

^b Millennium Predictive Medicine Inc   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

ALLELISM; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 8Q; DNA HYBRIDIZATION; DNA LIBRARY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE MARKER; OVARY TUMOR; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUPPRESSION SUBTRACTION HYBRIDIZATION; TUMOR SUPPRESSOR GENE;

AGED; CHROMOSOMES, HUMAN; DOWN-REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036143022     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Cancer statistics, 1999
2. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
3. The secretion and receptor gene of insulin-like growth factor-I quantitative expression in ovarian stroma in polycystic ovarian syndrome patients
4. DD/AP-PCR: Combination of differential display and arbitrarily primed PCR of oligo(dT) cDNA
5. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction
6. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer
7. Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer
8. Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis
9. Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions
10. Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries
11. Suppression subtractive hybridization: A versatile method for identifying differentially expressed genes
12. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: The insulin-like growth factor system
13. Experimental model systems of ovarian cancer: Applications to the design and evaluation of new treatment approaches
14. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer
15. Genetic linkage mapping of HSD3B1 and HSD3B2 encoding human types I and 11 3 β-hydroxysteroid dehydrogenase/δ5-δ4-isomerase close to D1S514 and the centromeric D1Z5 locus
16. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
17. ITM2A is induced during thymocyte selection and T cell activation and causes down-regulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes
18. FGF7 protein expression in human breast carcinomas
19. Exon sharing of a novel human zinc-finger gene, ZIM2, and paternally expressed gene 3 (PEG3)
20. Localization of the gene for a serine protease with IGF-binding domain (PRSS11) to human chromosome 10q25.3-q26.2
21. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22
22. Human epithelial ovarian cancer allelotype
23. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high-grade invasive epithelial ovarian cancer
24. Loss of heterozygosity in human ovarian cancer on chromosome 19q
25. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas
26. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
27. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer
28. Duplication of two distinct regions on chromosome 5q in non-papillary renal-cell carcinomas
29. Basic fibroblast growth factor and receptor expression in human ovarian cancer
30. The histone deacetylase-3 complex contains nuclear receptor corepressors
31. The diverse role of selenium within selenoproteins: A review
32. Genomic organization of the human SPOCK gene and its chromosomal localization to 5q31
33. Transcription factor SIII: A novel component of the RNA polymerase II elongation complex
34. Molecular genetic analysis of TGF-β1 in ovarian neoplasia
35. Human CDC23: Cdna cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias
36. Elevated egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-β type II receptor
37. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer
38. Expression of calcium-binding protein S100A2 in breast lesions
39. Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage
40. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl
41. Localization of human platelet proteoglycan gene to chromosome 10, band q22.1, by in situ hybridization
42. Complementary physical and genetic techniques map the vinculin (VCL) gene on chromosome 10q
43. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases
44. Protein targeting to glycogen/PPPIR5: Screening of coding and flanking genomic regions for polymorphisms and association analysis with insulin action in Pima Indians
45. Rapid upregulation of serum and glucocorticoidregulated kinase (sgk) gene expression by corticosteroids in vivo
46. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma
47. Genetic analysis of early- versus late-stage ovarian tumors
48. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics
49. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
50. Identification of homozygous deletions at chromosome 16q23 in Aflatoxin B1 exposed hepatocellular carcinoma
51. Promoter hypermethylation and homozygous deletion of the p14ARF and p161NK4a genes in oligodendrogliomas
52. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to α-folate receptor overexpression
53. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary
54. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis
55. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells
56. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRLI (FOXO3a)
57. Significance of multiple mutations in cancer
58. Cancer epigenetics comes of age
59. DNA methylation: Past, present and future directions
60. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI
61. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer
62. Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt’s lymphoma cell lines is related to methylation status of the gene
63. Nucleotide sequence of the cDNA coding for human complement Clr
64. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation